Antiperoxidant effects of dihydropyridine calcium antagonists
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (23) , 4344-4348
- https://doi.org/10.1016/0006-2952(89)90537-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”)Journal of the American College of Cardiology, 1988
- Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone+Journal of Molecular and Cellular Cardiology, 1988
- Calcium Antagonists in Cerebral/Peripheral Vascular DisordersDrugs, 1987
- Calcium Channel LigandsAnnual Review of Pharmacology and Toxicology, 1987
- Classification of calcium antagonistsThe American Journal of Cardiology, 1987
- Effects of calcium antagonists on infarcting myocardiumThe American Journal of Cardiology, 1987
- Calcium ions, drug action and the heart—with special reference to calcium antagonist drugsPharmacology & Therapeutics, 1984
- Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth musclesEuropean Journal of Pharmacology, 1983
- Tight binding inhibitors of xanthine oxidasePharmacology & Therapeutics, 1981
- Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridineJournal of Medicinal Chemistry, 1980